DBD
DIEBOLD NIXDORF, IncCompany with tickers: DBD
CIK
28823
CUSIP
253651202
Shares Outstanding
34,628,392
13F Activity (30d)
178 filings
175 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $891,800,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $213,100,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Expenses | $180,400,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Research & Development | $22,100,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Income | $32,700,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Net Income | $5,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $0.14 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $0.14 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |